Search

everythinglearnresearchcommunity

for

Search:↓

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Lower SHBG levels may increase the risk of PCOS.

Genetics and hormones play a role in male and female hair loss, but more research is needed to fully understand it.

Sex hormones, especially androgens, play a key role in causing acne.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Fadrozole and finasteride change gene expression related to sex hormones and thyroid hormones in frog larvae development.

Sex steroids influence skin appendage function and neoplasm development, with changes in AR and ERalpha in certain gland neoplasms.

SHBG may be a useful early indicator and treatment target for PCOS.

Both genetic and hormonal factors are crucial for bird sex differentiation, and disturbances can cause sex reversal.

Women may need different blood pressure guidelines than men for heart disease prevention.

Men with isolated hypogonadotropic hypogonadism have partial steroid deficiencies, while those with panhypopituitarism have severe deficiencies.

Human skin produces sex hormones like estrogen and testosterone, influenced by ARO and StAR, which may affect skin elasticity and hair growth.

Higher DHEAS levels may cause hair loss in women by disrupting hair growth.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

Prenatal antiandrogen treatment altered hormone levels in adult spotted hyenas, affecting males and females differently.

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.

SRD5A2 gene variations affect PTSD symptoms differently in males and females.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

Cross-sex hormone treatment in transsexual individuals helps understand how sex hormones affect diseases like heart disease and diabetes.

SHBG binding properties are unchanged in male liver cirrhosis patients.

Men with hair loss have lower SHBG and higher saliva testosterone levels, suggesting increased androgen activity.

The document concludes that there is a significant lack of reporting on the sex and age of cells in skin research, which could affect clinical trials and treatments.

Low testosterone and SHBG levels are linked to higher COVID-19 death rates.

Lower DHT levels lead to more body hair growth.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.